ANGUS Chemical Company, a leading global manufacturer and marketer of specialty and fine chemicals, today announced the appointment of Dave Neuberger as Chief Executive Officer (CEO), effective immediately. Mr. Neuberger succeeds Mark Henning, who will step down as CEO.
Mr. Neuberger is an industry veteran with 20 years of experience. He has held a variety of leadership roles with leading chemicals companies. He joins ANGUS after a decade with Ashland Inc., a global specialty chemicals company, where he most recently served as Group Vice President of the company’s Pharmaceutical, Agriculture and Nutrition Specialties business. In that role, Mr. Neuberger oversaw Ashland’s most profitable P&L, and he managed a pipeline of new product introductions. During his time at Ashland, Mr. Neuberger also led the company’s North American Industrial Specialties business, including all commercial, technical service and supply chain functions.
Robert Kirby, Chairman of the ANGUS Board of Directors, said: “Dave’s track record of building, growing and managing specialty chemicals businesses makes him the ideal person to lead ANGUS into its next chapter. Dave has decades of diverse leadership experience across the chemicals industry, as well as a strong, results-driven approach that will immediately create value and position ANGUS for future growth opportunities. We appreciate Mark’s decades of service to ANGUS, and are particularly grateful for his stewardship of the Company during the carve-out from the Dow Chemical Company. We look forward to working with Dave as we continue to grow the business.”
Mr. Neuberger said: “It is a privilege to join a company of ANGUS’ caliber and work alongside the talented ANGUS management team. ANGUS has an impressive customer base across a variety of end markets, and I am excited to support the Company’s mission to empower customers through science and technology and help steer ANGUS into its next phase.”
Rajeev Amara, a Managing Director at Golden Gate Capital and ANGUS Board member, added, “We are pleased to welcome Dave to the ANGUS team. This is an exciting moment in the Company’s history: ANGUS is the only vertically-integrated global provider of many of the foundational chemicals used in the production of next-generation medicine, including biologics and cell therapy, and we are confident that Dave’s experience and expertise in those sectors will significantly accelerate the Company’s growth.”
Prior to Ashland, Mr. Neuberger spent nearly a decade at W.R. Grace, where he most recently served as Manager of New Business Development at the company’s specialty chemicals and materials division. He earned a MBA in Finance from the University of Pennsylvania, where he was a Palmer Scholar, and a BS in Chemical Engineering from Johns Hopkins University.
Source: ANGUS Chemical Company
Neste Corporation’s Board of Directors has appointed Heikki Malinen, M.Sc. (Econ.), MBA (Harvard) as the President and CEO of Neste as of 2 November 2024, at the latest. Malinen joins Neste from Outokumpu Corporation where he has held the position of President and CEO since 2020.
Petrochemicals company Sasol has announced that CFO and executive director Hanré Rossouw will step down from his position, effective October 31. Sasol has started the process to appoint a successor. Rossouw will still oversee the publication of Sasol’s reports for the financial year ending June 30, to allow for a structured handover period.
Chemours announced its CFO Jonathan Lock has resigned from all positions within the company, according to an SEC 8-K filing on April 23. The resignation comes in the aftermath of the company announcing that Lock, former CEO Mark Newman, and principal accounting officer Camela Wisel, had been placed on administrative leave.
